resveratrol has been researched along with Heart Failure in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (10.34) | 29.6817 |
| 2010's | 22 (75.86) | 24.3611 |
| 2020's | 4 (13.79) | 2.80 |
| Authors | Studies |
|---|---|
| Netticadan, T; Raj, P; Thandapilly, SJ; Wigle, J; Zieroth, S | 1 |
| Chen, J; Ma, E; Peng, L; Ren, DN; Wo, D; Wu, C; Yan, H; Zhu, W | 1 |
| Gal, R; Habon, T; Halmosi, R; Kenyeres, P; Praksch, D; Rabai, M; Toth, K | 1 |
| Cebova, M; Dayar, E; Pechanova, O | 1 |
| Beker, DL; Byrne, NJ; Dyck, JRB; El-Kadi, AOS; Maayah, ZH; Masson, G; Matsumura, N; Parajuli, N; Shoieb, SM; Soltys, CM; Takahara, S | 1 |
| Dyck, GJB; Dyck, JRB; Ezekowitz, JA; Raj, P; Zieroth, S | 1 |
| Çağlar Torun, A; Tütüncü, Ş | 1 |
| Louis, XL; Movahed, A; Netticadan, T; Raj, P; Thandapilly, SJ; Zieroth, S | 1 |
| Gu, XS; Lei, JP; Li, L; Su, DF; Wang, ZB; Ye, Z; Zheng, X | 1 |
| Cao, Y; Dong, C; Duan, C; Li, J; Lu, D; Patel, J; Pu, L; Ruan, Y; Shen, T; Wang, X; Wu, X | 1 |
| Chen, J; Gao, M; Huang, X; Shen, X; Sun, J; Wang, L; Wang, Z; Xian, S; Yang, Z; Yuan, T | 1 |
| Dyck, JR; Sung, MM | 1 |
| Ahmet, I; Lakatta, EG; Tae, HJ; Talan, M | 1 |
| Acosta, C; Akinwumi, BC; Anderson, HD; Davies, NM; Lee, DI; Majeed, M; Nagabhushanam, K; Netticadan, T; Raj, P; Thomas, SM; Yu, L | 1 |
| Byrne, NJ; Denou, E; Dyck, JR; Fung, D; Jones, KE; Kim, TT; Levasseur, J; Robertson, IM; Samokhvalov, V; Schertzer, JD; Seubert, JM; Soltys, CL; Sung, MM; Tyreman, N | 1 |
| Bennett, JA; Danz, ED; Henry, N; Keller, RS; Skramsted, J | 1 |
| Wu, JM | 1 |
| Hisahara, S; Horio, Y; Ishikawa, S; Kuno, A; Miura, T; Shimamoto, K; Tanno, M; Yano, T | 1 |
| Chang, CC; Day, YJ; Deng, JY; Huang, JP; Huang, SS; Hung, LM | 1 |
| Gupta, MP; Pillai, VB; Sundaresan, NR | 1 |
| Li, JJ; Qian, HY; Wang, H; Xu, H; Yang, YJ; Zhang, Q | 1 |
| Fortin, D; Garnier, A; Mateo, P; Piquereau, J; Rimbaud, S; Ruiz, M; Veksler, V; Ventura-Clapier, R | 1 |
| dos Santos, CC; Furmli, S; Haitsma, JJ; Horvath, E; Hu, P; Kuiper, JW; Leong-Poi, H; Masoom, H; Parker, TG; Plötz, FB; Shan, Y; Slutsky, AS; Smeding, L | 1 |
| Fernandes, CJ; Santucci Assunção, M | 1 |
| Bin, J; Chen, B; Chen, C; Liao, Y; Wu, B; Xu, D; Xuan, W; Zhang, W | 1 |
| Forini, F; Iervasi, G; Sabatino, L | 1 |
| Fujiwara, H; Fujiwara, T; Goto, K; Kanamori, H; Kawaguchi, T; Kawasaki, M; Mikami, A; Minatoguchi, S; Morishita, K; Ogino, A; Seishima, M; Takemura, G; Takeyama, T; Tsujimoto, A; Watanabe, T | 1 |
| Feng, JK; Li, Q; Song, CM; Wang, GY; Wang, N; Wang, YM; Yue, H; Zhang, LN | 1 |
| Alcendor, RR; Hsu, CP; Odewale, I; Sadoshima, J | 1 |
8 review(s) available for resveratrol and Heart Failure
| Article | Year |
|---|---|
A Comprehensive Analysis of the Efficacy of Resveratrol in Atherosclerotic Cardiovascular Disease, Myocardial Infarction and Heart Failure.
Topics: Animals; Atherosclerosis; Cardiovascular Diseases; Heart Failure; Humans; Myocardial Infarction; Resveratrol | 2021 |
Therapeutic Potential of Polyphenols-Loaded Polymeric Nanoparticles in Cardiovascular System.
Topics: Animals; Antioxidants; Atherosclerosis; Biological Availability; Biological Products; Cardiovascular System; Curcumin; Drug Compounding; Heart Failure; Humans; Hypertension; Nanocapsules; Nitric Oxide; Nitric Oxide Synthase Type III; Polymers; Polyphenols; Quercetin; Reactive Oxygen Species; Resveratrol | 2020 |
The Effects of Resveratrol in Patients with Cardiovascular Disease and Heart Failure: A Narrative Review.
Topics: Anti-Inflammatory Agents; Biomarkers; Blood Pressure; Cardiovascular Diseases; Endothelial Cells; Heart Failure; Humans; Hypoglycemic Agents; Resveratrol; Treatment Outcome; Ventricular Function, Left | 2019 |
Potential of resveratrol in the treatment of heart failure.
Topics: Animals; Cardiotonic Agents; Heart Failure; Humans; Resveratrol; Stilbenes; Vitis | 2014 |
Therapeutic potential of resveratrol in heart failure.
Topics: Animals; Cardiotonic Agents; Heart Failure; Humans; Resveratrol; Stilbenes | 2015 |
Emerging roles of SIRT1 deacetylase in regulating cardiomyocyte survival and hypertrophy.
Topics: Animals; Cardiomegaly; Cell Survival; Coronary Vessels; Enzyme Activators; Gene Expression; Heart Failure; Humans; Myocardium; Myocytes, Cardiac; Neovascularization, Physiologic; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes | 2011 |
Resveratrol in cardiovascular disease: what is known from current research?
Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Antioxidants; Cardiovascular Diseases; Heart Failure; Humans; Resveratrol; Sirtuin 1; Stilbenes | 2012 |
Sirt1 protects the heart from aging and stress.
Topics: Aging; Animals; Apoptosis; Caloric Restriction; Heart; Heart Diseases; Heart Failure; Humans; Longevity; Mice; Nicotinamide Phosphoribosyltransferase; Oxidative Stress; Resveratrol; Saccharomyces cerevisiae; Sirtuin 1; Sirtuins; Stilbenes; Up-Regulation | 2008 |
1 trial(s) available for resveratrol and Heart Failure
| Article | Year |
|---|---|
Hemorheological Alterations in Patients with Heart Failure with Reduced Ejection Fraction Treated by Resveratrol.
Topics: Aged; Cardiovascular Agents; Double-Blind Method; Erythrocyte Aggregation; Exercise Tolerance; Female; Heart Failure; Humans; Hungary; Male; Middle Aged; Resveratrol; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left | 2020 |
20 other study(ies) available for resveratrol and Heart Failure
| Article | Year |
|---|---|
Resveratrol prevents Ang II-induced cardiac hypertrophy by inhibition of NF-κB signaling.
Topics: Angiotensin II; Animals; Cardiomegaly; Heart Failure; Mice; Myocytes, Cardiac; NF-kappa B; Rats; Resveratrol; Signal Transduction | 2023 |
Resveratrol improves cardiac function and exercise performance in MI-induced heart failure through the inhibition of cardiotoxic HETE metabolites.
Topics: Animals; Chromatography, Liquid; Heart Failure; Hydroxyeicosatetraenoic Acids; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Resveratrol; Spectrometry, Mass, Electrospray Ionization | 2018 |
Assessing the therapeutic effect of resveratrol in heart failure following blunt chest trauma and the potential role of endocan as a biomarker of inflammation using rats.
Topics: Animals; Antioxidants; Biomarkers; Heart Failure; Inflammation; Male; Nitric Oxide Synthase Type II; Proteoglycans; Random Allocation; Rats; Resveratrol; Thoracic Injuries; Tumor Necrosis Factor-alpha; Wounds, Nonpenetrating | 2019 |
Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure.
Topics: AMP-Activated Protein Kinases; Animals; Cell Line; Cells, Cultured; Heart Failure; Male; Mice; Myocardial Infarction; Myocytes, Cardiac; Niacinamide; Rats; Resveratrol; Sirtuin 1; Stilbenes; Up-Regulation; Ventricular Function | 2014 |
SIRT1 suppresses doxorubicin-induced cardiotoxicity by regulating the oxidative stress and p38MAPK pathways.
Topics: Animals; Apoptosis; Cell Line; Doxorubicin; Gene Expression Regulation; Heart Failure; Humans; Mice; Myocytes, Cardiac; Niacinamide; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Rats; Resveratrol; Signal Transduction; Sirtuin 1; Stilbenes | 2015 |
Resveratrol Ameliorates Pressure Overload-induced Cardiac Dysfunction and Attenuates Autophagy in Rats.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Autophagy; Blotting, Western; Cardiotonic Agents; Disease Models, Animal; Heart Failure; Heart Function Tests; Hypertension; Male; Myocardium; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2015 |
Long-term low dose dietary resveratrol supplement reduces cardiovascular structural and functional deterioration in chronic heart failure in rats.
Topics: Animals; Cardiotonic Agents; Chronic Disease; Collagen; Dietary Supplements; Disease Models, Animal; Drug Administration Schedule; Echocardiography; Fibrosis; Heart Failure; Male; Myocardial Contraction; Myocardium; Pulse Wave Analysis; Rats, Wistar; Resveratrol; Stilbenes; Stroke Volume; Time Factors; Vascular Stiffness; Ventricular Function, Left; Ventricular Remodeling | 2017 |
Disparate Effects of Stilbenoid Polyphenols on Hypertrophic Cardiomyocytes In Vitro vs. in the Spontaneously Hypertensive Heart Failure Rat.
Topics: Animals; Blood Pressure; Cardiomegaly; Cell Survival; Disease Models, Animal; Heart Failure; Heart Function Tests; MAP Kinase Signaling System; Myocytes, Cardiac; Polyphenols; Rats; Rats, Inbred SHR; Resveratrol; Stilbenes | 2017 |
Resveratrol improves exercise performance and skeletal muscle oxidative capacity in heart failure.
Topics: Animals; Antioxidants; Energy Metabolism; Exercise Tolerance; Fatigue; Glucose; Heart Failure; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Microbiota; Muscle, Skeletal; Oxidation-Reduction; Oxygen Consumption; Physical Conditioning, Animal; Physical Exertion; Resveratrol; Stilbenes; Stroke Volume | 2017 |
Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway.
Topics: Animals; Cardiotonic Agents; Cell Death; Cells, Cultured; Doxorubicin; Drug Evaluation, Preclinical; Heart Failure; Mitochondria, Heart; Myocytes, Cardiac; Niacinamide; Oxidative Stress; Rats; Reactive Oxygen Species; Resveratrol; Sirtuin 1; Sirtuins; Stilbenes; Structure-Activity Relationship | 2009 |
Resveratrol alleviates some cardiac dysfunction indexes in an SHR model of essential hypertension.
Topics: Animals; Antioxidants; Cardiomegaly; Cardiotonic Agents; Chronic Disease; Heart Diseases; Heart Failure; Hypertension; Myocardial Contraction; Rats; Rats, Inbred SHR; Resveratrol; Stilbenes | 2010 |
Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure.
Topics: Adult; Animals; Cardiomyopathy, Dilated; Cell Nucleus; Cell Survival; Cells, Cultured; Chronic Disease; Cricetinae; Disease Models, Animal; Enzyme Activation; Heart Failure; Humans; Male; Mesocricetus; Mice; Muscle Fibers, Skeletal; Myocardial Infarction; Myocytes, Cardiac; Oxidative Stress; Phenols; Plant Extracts; Rats; Resveratrol; Sirtuin 1; Stilbenes; Superoxide Dismutase | 2010 |
Insulin and resveratrol act synergistically, preventing cardiac dysfunction in diabetes, but the advantage of resveratrol in diabetics with acute heart attack is antagonized by insulin.
Topics: Acute Disease; Animals; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Drug Antagonism; Drug Evaluation, Preclinical; Drug Synergism; Heart Failure; Hemodynamics; Hypoglycemic Agents; Insulin; Male; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Streptozocin; Vasodilator Agents | 2010 |
Resveratrol improves survival, hemodynamics and energetics in a rat model of hypertension leading to heart failure.
Topics: Animals; Body Weight; Disease Models, Animal; Endothelium, Vascular; Energy Metabolism; Heart; Heart Failure; Hemodynamics; Hypertension; Male; Mitochondria; Rats; Rats, Inbred Dahl; Resveratrol; Signal Transduction; Stilbenes; Survival Analysis | 2011 |
Salutary effect of resveratrol on sepsis-induced myocardial depression.
Topics: Animals; Cardiomyopathies; Cecum; Down-Regulation; Edema; Gene Expression; Heart Failure; Ligation; Male; Mice; Mice, Inbred C57BL; Mitochondria, Heart; Myocardial Contraction; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Random Allocation; Resveratrol; Sepsis; Stilbenes; Trans-Activators; Transcription Factors; Vasodilator Agents | 2012 |
In vino veritas? Pliny the Elder.
Topics: Animals; Heart Failure; Male; Myocardial Contraction; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Resveratrol; Sepsis; Stilbenes; Trans-Activators; Transcription Factors; Vasodilator Agents | 2012 |
Resveratrol improves myocardial ischemia and ischemic heart failure in mice by antagonizing the detrimental effects of fractalkine*.
Topics: Animals; Animals, Newborn; Chemokine CX3CL1; Disease Models, Animal; Electrocardiography; Heart Failure; Male; Mice; Mice, Inbred C57BL; Myocardial Ischemia; Platelet Aggregation Inhibitors; Random Allocation; Rats; Resveratrol; Stilbenes; Ventricular Remodeling | 2012 |
A glass of wine: how good is good? The resveratrol lesson*.
Topics: Animals; Chemokine CX3CL1; Heart Failure; Male; Myocardial Ischemia; Platelet Aggregation Inhibitors; Resveratrol; Stilbenes | 2012 |
Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Animals, Newborn; Apoptosis; Autophagy; Cells, Cultured; Densitometry; Energy Metabolism; Heart Failure; Heart Function Tests; Male; Mice; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Resveratrol; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sirtuin 1; Stilbenes; Superoxide Dismutase; TOR Serine-Threonine Kinases; Vacuoles; Ventricular Remodeling | 2013 |
[Effect of resveratrol on heart function of rats with adriamycin-induced heart failure].
Topics: Animals; Doxorubicin; Heart; Heart Failure; Male; Malondialdehyde; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Random Allocation; Rats; Rats, Sprague-Dawley; Resveratrol; Stilbenes; Superoxide Dismutase | 2007 |